86 related articles for article (PubMed ID: 21216092)
21. Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression.
Zhang W; Zhou H; Yu Y; Li J; Li H; Jiang D; Chen Z; Yang D; Xu Z; Yu Z
Onco Targets Ther; 2016; 9():3359-68. PubMed ID: 27330316
[TBL] [Abstract][Full Text] [Related]
22. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
23. Gambogic acid enhances the radiosensitivity of human esophageal cancer cells by inducing reactive oxygen species via targeting Akt/mTOR pathway.
Yang Y; Sun X; Yang Y; Yang X; Zhu H; Dai S; Chen X; Zhang H; Guo Q; Song Y; Wang F; Cheng H; Sun X
Tumour Biol; 2016 Feb; 37(2):1853-62. PubMed ID: 26318432
[TBL] [Abstract][Full Text] [Related]
24. Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi.
Jia B; Li S; Hu X; Zhu G; Chen W
AAPS PharmSciTech; 2015 Aug; 16(4):742-58. PubMed ID: 26152816
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro.
Chen J; Zhou M; Zhang Q; Xu J; Ouyang J
Med Sci Monit; 2015 Jun; 21():1604-10. PubMed ID: 26049398
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effects of isomorellin and forbesione with doxorubicin on apoptosis induction in human cholangiocarcinoma cell lines.
Hahnvajanawong C; Wattanawongdon W; Chomvarin C; Anantachoke N; Kanthawong S; Sripa B; Reutrakul V
Cancer Cell Int; 2014; 14():68. PubMed ID: 25866479
[TBL] [Abstract][Full Text] [Related]
27. Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.
Wang X; Feng Y; Wang N; Cheung F; Tan HY; Zhong S; Li C; Kobayashi S
Biomed Res Int; 2014; 2014():530342. PubMed ID: 25379508
[TBL] [Abstract][Full Text] [Related]
28. ROS-mediated autophagy induced by dysregulation of lipid metabolism plays a protective role in colorectal cancer cells treated with gambogic acid.
Zhang H; Lei Y; Yuan P; Li L; Luo C; Gao R; Tian J; Feng Z; Nice EC; Sun J
PLoS One; 2014; 9(5):e96418. PubMed ID: 24810758
[TBL] [Abstract][Full Text] [Related]
29. HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.
Huang H; Liu N; Yang C; Liao S; Guo H; Zhao K; Li X; Liu S; Guan L; Liu C; Xu L; Zhang C; Song W; Li B; Tang P; Dou QP; Liu J
PLoS One; 2012; 7(12):e52576. PubMed ID: 23285100
[TBL] [Abstract][Full Text] [Related]
30. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
Zhang DC; Liu JL; Ding YB; Xia JG; Chen GY
Acta Pharmacol Sin; 2013 Feb; 34(2):301-8. PubMed ID: 23274410
[TBL] [Abstract][Full Text] [Related]
31. Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.
Felth J; Lesiak-Mieczkowska K; D'Arcy P; Haglund C; Gullbo J; Larsson R; Linder S; Bohlin L; Fryknäs M; Rickardson L
Invest New Drugs; 2013 Jun; 31(3):587-98. PubMed ID: 23179339
[TBL] [Abstract][Full Text] [Related]
32. L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro.
Huang H; Liu N; Guo H; Liao S; Li X; Yang C; Liu S; Song W; Liu C; Guan L; Li B; Xu L; Zhang C; Wang X; Dou QP; Liu J
PLoS One; 2012; 7(11):e49062. PubMed ID: 23139833
[TBL] [Abstract][Full Text] [Related]
33. Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1.
Wang C; Zhang H; Chen Y; Shi F; Chen B
Int J Nanomedicine; 2012; 7():781-7. PubMed ID: 22393285
[TBL] [Abstract][Full Text] [Related]
34. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.
Liu N; Huang H; Xu L; Hua X; Li X; Liu S; Yang C; Zhao C; Zhao C; Li S; Dou QP; Liu J
Toxicol Lett; 2014 Jan; 224(3):333-40. PubMed ID: 24291039
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
[TBL] [Abstract][Full Text] [Related]
36. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation.
Liu N; Huang H; Liu S; Li X; Yang C; Dou QP; Liu J
Toxicol In Vitro; 2014 Apr; 28(3):419-25. PubMed ID: 24373880
[TBL] [Abstract][Full Text] [Related]
37. Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells.
Nagy K; Petak I; Imre G; Barna G; Gezane-Csorba M; Sebestyen A; Houghton JA; Mihalik R; Kopper L
Anticancer Res; 2005; 25(5):3321-6. PubMed ID: 16101145
[TBL] [Abstract][Full Text] [Related]
38. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
39. Gambogic acid enhances proteasome inhibitor-induced anticancer activity.
Huang H; Chen D; Li S; Li X; Liu N; Lu X; Liu S; Zhao K; Zhao C; Guo H; Yang C; Zhou P; Dong X; Zhang C; Guanmei ; Dou QP; Liu J
Cancer Lett; 2011 Feb; 301(2):221-8. PubMed ID: 21216092
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
